Max Healthcare Institute Ltd Share Price

Hospitals / Medical Services

NSE: MAXHEALTH Large Cap ISIN: INE027H01010

As on 31 January 2025 at 14:04 IST

₹1,058.45

+ 14.60

(1.40%)

Sell Buy

About Max Healthcare Institute Ltd

Max Healthcare Institute Ltd. is one of the largest healthcare organizations in India. It provides a wide range of medical services and facilities. The company was founded in 2001. Max Healthcare Institute has grown to become a significant player in the Indian healthcare industry. The headquarters of the company is located in New Delhi. Its main products and services include hospital services, homecare services (Max@Home), and pathology services (Max Labs). The company falls under the healthcare sector. The company is known for its comprehensive range of medical services and strong market presence. Read More...

Over 1 Month

-10.18%

Over 6 Months

13.70%

Over 1 Year

41.75%

Over 3 Years

184.08%

Max Healthcare Institute Ltd Summary

Close ₹ 1,058.45

Open ₹ 1,046

High ₹ 1,064.05

Low ₹ 1,029.75

Volume 21,80,091

Net Turnover (in ₹ Cr) ₹ 409.48

52Wk High ₹ 1,227.95

52Wk Low ₹ 706.45

52Wk High / Low

706.45

1,227.95

Max Healthcare Institute Ltd Fundamentals

Key Financial Data

Market Cap (in ₹Cr) ₹ 1,01,476

EPS (TTM) 8.08

Book Value (BV) 81.73

Div. Yield 0.14 %

P/E (TTM) 129.03

Price/Book Value 12.76

Delivery % 49.07 %

Face Value 10

Key Ratios

PE Ratio 116.04

PB Ratio 10.38

EV to Sales 32.48

PEG Ratio -103.71

ROA 8.43

ROE 9.34

Debt-Equity 0.07

Net Profit Margin 28.10

Operating Profit Margin 42.24

Max Healthcare Institute Ltd Financials

Profit and Loss

Consolidated

Standalone

Yearly

Quarterly

Particulars (in ₹ Cr.)	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Total Revenue	5,584.09	4,701.84	4,058.82	2,619.41	1,956.85
Total Expenses	4,218.77	3,638.12	3,310.89	2,454.36	1,867.77
Profit Before Tax	1,365.32	1,063.72	738.90	-68.65	89.08
Profit After Tax	1,057.64	1,103.51	605.05	-114.50	95.34
Operating Profit after Depreciation	1,425.21	1,147.58	848.80	344.51	241.74

Balance Sheet

Particulars (in ₹ Cr.)	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Fixed Assets	8,828.45	7,084.58	7,063.97	6,536.59	2,379.89
Total Non Current Assets	10,293.76	8,158.78	8,188.84	7,419.97	3,056.06
Total Current Assets	1,706.18	1,943.07	1,000.29	1,124.47	768.32
TOTAL ASSETS	11,999.94	10,101.85	9,189.13	8,544.44	3,824.38
Total Shareholder's Fund	8,408.14	7,409.59	6,282.47	5,638.68	987.41

Cash Flow

Particulars (in ₹ Cr.)	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Net Cash from Operating Activities	1,121.80	1,284.13	740.52	117.86	249.82
Net Cash used in Investing Activities	-1,252.55	-102.21	-763.80	206.39	-126.68
Net Cash used in Financing Activities	-263.74	-288.56	-294.17	191.33	144.05

Particulars (in ₹ Cr.)	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Total Revenue	2,612.58	2,048.83	1,903.48	1,137.29	1,149.97
Total Expenses	1,747.62	1,485.69	1,502.99	1,073.08	1,123.17
Profit Before Tax	864.96	563.14	400.49	-146.46	26.80
Profit After Tax	687.26	694.31	331.52	-164.45	26.80
Operating Profit after Depreciation	916.62	615.05	459.42	176.66	116.63

Balance Sheet

Particulars (in ₹ Cr.)	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Fixed Assets	4,823.40	4,530.46	4,539.21	2,989.15	580.92
Total Non Current Assets	8,042.11	6,984.28	7,099.32	6,181.10	1,854.79
Total Current Assets	1,026.76	1,436.05	712.44	961.85	656.27
TOTAL ASSETS	9,068.87	8,420.33	7,811.76	7,142.95	2,511.06
Total Shareholder's Fund	7,680.76	7,042.11	6,311.38	5,939.43	1,246.04

Cash Flow

Particulars (in ₹ Cr.)	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Net Cash from Operating Activities	613.09	696.47	447.36	224.47	128.11
Net Cash used in Investing Activities	-805.64	-842.85	-669.65	-104.87	-192.61
Net Cash used in Financing Activities	-245.91	-54.47	-161.48	412.41	329.36

Particulars (in ₹ Cr.)	2024-12	2024-09	2024-06	2024-03	2023-12
Total Revenue	1,868.31	1,707.46	1,542.95	1,422.90	1,334.97
Total Expenses	1,369.18	1,256.92	1,155.54	1,041.37	949.11
Profit Before Tax	308.87	373.69	321.31	335.73	359.68
Profit After Tax	238.80	281.81	236.27	251.54	289.34
Operating Profit after Depreciation	532.43	491.38	422.09	426.78	431.88

Particulars (in ₹ Cr.)	2024-12	2024-09	2024-06	2024-03	2023-12
Total Revenue	697.40	686.11	621.39	610.11	590.75
Total Expenses	461.36	461.44	423.32	410.68	390.60
Profit Before Tax	198.18	318.15	203.16	290.62	203.33
Profit After Tax	138.24	231.30	154.14	241.77	158.12
Operating Profit after Depreciation	328.05	358.18	240.94	337.20	242.83

Max Healthcare Institute Ltd Technicals

Support and Resistance

S3 S2 S1 Pivot R1 R2 R3

S1 1,008.43

S2 973.02

S3 948.03

Pivot 1,033.42

R1 1,068.83

R2 1,093.82

R3 1,129.23

Moving Average

20 SMA 1,092.16

50 SMA 1,097.25

100 SMA 1,036

200 SMA 949.32

Max Healthcare Institute Ltd Corporate Actions

Dividend

Bonus

Splits

Rights

AGM

EGM

Max Healthcare Institute Ltd

₹1.5/Share

Announcement Date 23 Aug 2024

Record Date 23 Aug 2024

Div Yield 15%

Max Healthcare Institute Ltd Peer Comparison

Company	Price	Market Cap (in ₹ Cr)
Max Healthcare Institute Ltd	₹1,042.60	₹1,01,354.49
Apollo Hospitals Enterprise Ltd	₹6,827.55	₹98,169.69
Fortis Healthcare Ltd	₹648.40	₹48,951.49
Syngene International Ltd	₹758.45	₹30,530.42
Global Health Ltd	₹1,048	₹28,147.96
Narayana Hrudayalaya Ltd	₹1,302.75	₹26,623.10

Max Healthcare Institute Ltd News

Max Healthcare Institute board approves amendment to lease agreement for proposed hospital in Zirakpur, Punjab

At meeting held on 30 January 2025

30 Jan 2025, 03:41 pm

Board of Max Healthcare Institute approves lease agreement for 500-bed hospital in Thane

At meeting held on 30 January 2025

30 Jan 2025, 03:39 pm

Board of Max Healthcare Institute approves issuance of corporate guarantee for Nirogi

At meeting held on 30 January 2025

30 Jan 2025, 03:37 pm

Board of Max Healthcare Institute approves investment of Rs 125 cr in Jaypee Healthcare

At meeting held on 30 January 2025

30 Jan 2025, 03:35 pm

Max Healthcare Institute allots 10,000 equity shares under ESOS

29 Jan 2025, 11:45 am

Max Healthcare Institute Ltd Stock Analysis

Annual revenue for Max Healthcare Institute Ltd increased by 27.52% to ₹2,612.58 crore in FY 2024 from ₹2,048.83 crore in FY 2023.
Annual Net Profit for Max Healthcare Institute Ltd decreased by 1.02% to ₹687.26 crore in FY 2024 from ₹694.31 crore in FY 2023.
Promoter Shareholding in Max Healthcare Institute Ltd remains unchanged by 0.00% in the most recent quarter, from 23.74% in September 2024 to 23.74% in December 2024.
Max Healthcare Institute Ltd delivered a 1-year return of 41.75% compared to the Nifty 50, which provided a return of 8.03% as of the last trading session.
Max Healthcare Institute Ltd share price moved up by 1.40% from its previous close of INR ₹1,043.85. The latest Max Healthcare Institute Ltd share price is INR ₹1,058.45.
Max Healthcare Institute Ltd share price today has been at a low of 1,029.75 and a high of 1,064.05. Over the past 52 weeks, the Max Healthcare Institute Ltd share price has seen a low of 706.45 and a high of 1,227.95.

About Max Healthcare Institute Ltd

Max Healthcare Institute Ltd. is one of the largest healthcare organizations in India. The company provides a wide range of medical services and facilities. It operates hospitals, home care services, and pathology services under the brand names Max@Home and Max Labs, respectively. Max Healthcare is dedicated to delivering high standards of clinical excellence and patient care. These things are supported by the latest technology and cutting-edge research.

Max Healthcare falls under the healthcare sector. The company was founded in 2001, making it over many years old. Since its inception, Max Healthcare has grown to become a significant player in the Indian healthcare industry. The company is known for its comprehensive medical services and patient-centric approach.

The headquarters of Max Healthcare Institute Ltd. is located in New Delhi, India. The company is promoted and led by Abhay Soi, who serves as the Chairman and Managing Director. His leadership has been instrumental in driving the company's growth and success.

Max Healthcare's main products and services include homecare services, hospital services, and pathology services. The company operates 23 healthcare facilities with more than 5,150 beds. It offers a wide range of specialties and medical services. Max@Home provides health and wellness services at home. In comparison, Max Labs offers pathology services outside the hospital network.

Max Healthcare is one of the largest healthcare providers in India, with a strong market presence and a reputation for excellence. The company has an extensive network of hospitals and a comprehensive range of medical services. This has positioned it as a trusted and reliable healthcare provider.

The promoter shareholding of the company stands at 23.74%. This shareholding in Max Healthcare Institute Ltd. is held by Abhay Soi and his associates. Abhay Soi owns 23.73% of the stake from total shareholding. Also, he serves as the chairman and managing director of the company. This demonstrates strong promoter commitment to the business.
The crucial managerial promoters of the company include:

Pranav Amin
Michael Thomas Neeb
K Narasimha Murthy
Anil Kumar Bhatnagar

The registered office of Max Healthcare Institute Ltd. is located at 401, 4th Floor, Man Excellenza, S. V. Road, Mumbai - 400056, Maharashtra, India. Its registrar & transfer agent is KFin Technologies Private Limited.

Influence of the Company

Max Healthcare Institute Ltd. is one of the largest healthcare organizations in India, providing a wide range of medical services and facilities. The company operates hospitals, home care services, and pathology services. Max Healthcare has grown to become a significant player in the Indian healthcare industry. The company is committed to its clinical excellence, patient care, and innovation. This has solidified its position as a trusted name in the healthcare industry.

Economic Impact
Max Healthcare has had a substantial economic impact on the Indian healthcare sector. The company provides a wide range of medical services. Thus, it has facilitated access to quality healthcare for millions of individuals and families. The availability of hospital services, homecare services, and pathology services has enabled individuals to receive timely and effective medical care. This contributes to improved health outcomes and overall well-being. Additionally, this has contributed to economic stability and growth in the regions where Max Healthcare operates.

Patient-Centric Approach
One of the significant influences of Max Healthcare is its patient-centric approach. The company focuses on understanding and meeting the specific needs of its patients. This ensures that they receive personalized and comprehensive medical care. Max Healthcare's commitment to patient satisfaction has resulted in high patient retention rates and long-term relationships with patients. The company's emphasis on patient-centricity has set new standards in the healthcare industry. Also, this encourages other players to adopt similar practices.

Innovation and Technological Advancements
Max Healthcare is at the forefront of innovation and technological advancements in the healthcare sector. The company leverages advanced technologies such as digital health platforms, telemedicine, and artificial intelligence to enhance its operations and improve patient experience. Max Healthcare embraces these technologies. Thus, the company has improved its operational efficiency, reduced treatment times, and provided innovative medical solutions to its patients. These technological advancements have positioned Max Healthcare as a leader in the healthcare industry.

Corporate Social Responsibility
Max Healthcare is committed to corporate social responsibility (CSR). Also, it undertakes various initiatives to support community development. The company's CSR activities focus on healthcare, education, and environmental sustainability. By investing in these areas, Max Healthcare has made a positive impact on the lives of many individuals and communities, fostering social and economic development. The company's CSR initiatives have also enhanced its reputation as a socially responsible and ethical organization.

Max Healthcare Institute Ltd. has made a significant impact on the Indian healthcare sector and the economy. The company has contributed to improved health outcomes and economic growth. This is achieved through its comprehensive range of medical services, patient-centric approach, innovation, and technological advancements. Max Healthcare's focus on corporate social responsibility has further enhanced its influence and reputation. As the company continues to evolve and expand its operations, it remains dedicated to driving healthcare excellence and improving the quality of life for its patients and communities.